Vaccine-Preventable Diseases

Top Story

ACIP recommends that LAIV should not be used

June 23, 2016

In a reversal of its recommendation last year, the CDC Advisory Committee on Immunization Practices has voted to approve an update for the 2016-2017 season stating that the live attenuated influenza vaccine, offered as a nasal spray, should not be used in any setting.

In a 13-1 vote, with one abstention, members of the committee approved the interim recommendation based on the reported ineffectiveness of the live attenuated influenza vaccine (LAIV) over the last three influenza seasons. Data reviewed both by the Advisory Committee on Immunization Practices (ACIP) and its working group indicated the LAIV had been ineffective against influenza A (H1N1) in children aged 2 to 17 years. It also performed poorly in a study among active military.

ACIP recommends cholera vaccine for travelers

June 22, 2016
The Advisory Committee on Immunization Practices voted unanimously today to accept proposed recommendations for a single-dose, live, oral cholera vaccine. The vaccine…
In the Journals

Maternal HBsAg comparable to viral load in predicting HBV in infants

June 21, 2016
Recent findings published in Hepatology showed that quantitative maternal hepatitis B surface antigen predicted chronic hepatitis B virus infection in infants at an…
In the JournalsPerspective

Access to detailed VAERS reports reduces vaccine acceptance

June 20, 2016
Recent research in Vaccine found that exposure to detailed reports from the FDA and CDC’s vaccine adverse events reporting system decreased both trust in the CDC…
CME

Vaccines in the Pipeline: The Path from Development to Use in the United States

Pediatric Annals, August 2013, Volume 42 Issue 8
CME Educational Objectives 1.Review the current US Food and Drug Administration licensure process for vaccines. 2…
More »
CME Video

Operation Immunization 2016: Enhancing HPV Immunization

This activity is supported by an educational grant from Merck & Co. Inc.

During the last decade, several new vaccines, including the meningococcal conjugate (MCV4), tetanus, diphtheria…
More »
Featured
PAS 2016

PAS 2016

Video
Meeting News Coverage

VIDEO: Flublok demonstrates superior efficacy over IIV

April 21, 2016
More »
In the Journals

Strong recommendations for HPV vaccine lacking among pediatricians, family practitioners

January 5, 2016
Nearly one-third of physicians reported not strongly recommending HPV vaccination at patients’ 11-12 year well visit, and they were even less…

In the Journals

BCG vaccine demonstrates long-lasting effectiveness

December 28, 2015
Recent data showed the bacille Calmette-Guérin vaccine reduced the risk for tuberculosis after 40 years of vaccination, suggesting the vaccine…

WHO agrees to review Merck’s Ebola vaccine for emergency use

December 23, 2015
Merck announced that the application for Emergency Use Assessment and Listing for its investigational Ebola vaccine has been accepted by WHO for…

In the Journals

Influenza vaccine effectively treats obese children

December 23, 2015
Influenza vaccine was effective among a cohort of obese children, a population that tends to have longer duration of illness when infected, according…

Perspective

Infants infected with vaccine-derived polio in Myanmar

December 22, 2015
Two children have contracted circulating vaccine-derived poliovirus type 2 with accompanying acute flaccid paralysis in Myanmar, according to WHO…

In the Journals

Vaccine coverage among teens with chronic health conditions above average

December 18, 2015
Vaccine coverage among adolescents with chronic health conditions was greater than that of healthy adolescents, highlighting important gaps in…

In the Journals

Incentives improve rabies vaccination coverage

December 17, 2015
Recent findings published in PLoS Neglected Tropical Diseases showed that brightly colored dog collars and owner wristbands, which distinguished…

FDA News

FDA expands Gardasil 9 HPV vaccine approval to boys, young men

December 16, 2015
The FDA expanded the age indication for Gardasil 9 HPV vaccine to include boys and men aged 16 to 26 years, according to a press release from Merck…

Meeting News Coverage

Investigational hexavalent vaccine safe, effective when given with RotaTeq, Prevnar 13

Infectious Diseases in Children, December 2015
An investigational combination hexavalent vaccine for protection against diphtheria, tetanus, pertussis, poliovirus, Haemophilus influenzae type b…

In the Journals

Home intervention, education improve childhood vaccination rates

December 8, 2015
Among children at high risk for poor health outcomes, home interventions with trained health care workers who provided information and education…

More Headlines »
morganatic-roan
morganatic-roan